Advertisement

Masterclass: Axial spondyloarthritis for osteopaths and manual therapists

      Abstract

      Axial Spondyloarthritis (axial SpA) is an inflammatory arthritis primarily affecting the sacroiliac joints (SIJ) and spine and is a spectrum of disease which includes the more commonly known Ankylosing Spondylitis. Axial SpA is often missed in musculoskeletal assessments, and mismanaged and treated as chronic low back pain. Early diagnosis and intervention are essential to improve outcomes and so it is vital that people presenting with back pain are screened for axial SpA.
      This masterclass aims to improve clinicians’ understanding and awareness of axial SpA, including screening, recognition and when to refer to rheumatology. This article will familiarise clinicians with typical clinical features, appropriate investigation and interpretation, referral pathways in line with UK National Institute of Clinical Excellence (NICE) guidelines and advise on best practice for clinicians managing axial SpA.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Dagfinrud H.
        • Mengshoel A.
        • Hagen K.
        • Loge J.H.
        • Kvien T.
        Health status of patients with ankylosing spondylitis: a comparison with the general population.
        Ann Rheum Dis. 2004; 63: 1605-1610
        • Zhang L.
        • Wu Y.
        • Liu S.
        • Zhu W.
        Prevalence of depression in ankylosing spondylitis: a systematic review and meta-analysis.
        Psychiatr Invest. 2019; 16: 565
      1. Nice. Spondyloarthritis in over 16's :diagnosis and management national institute of clinical excellence 2017.
        ([cited 2020 03/03/2020]. Available from:)
        • Hamilton L.
        • Macgregor A.
        • Toms A.
        • Warmington V.
        • Pinch E.
        • Gaffney K.
        The prevalence of axial spondyloarthritis in the UK: a cross-sectional cohort study.
        BMC Muscoskel Disord. 2015; 16: 392
        • Sieper J.
        • Poddubnyy D.
        Axial spondyloarthritis.
        Lancet. 2017; 390: 73-84
        • Rusman T.
        • van Vollenhoven R.
        • van der Horst-Bruinsma I.
        Gender differences in axial spondyloarthritis: women are not so lucky.
        Curr Rheumatol Rep. 2018; 20: 35
        • Yi E.
        • Ahuja A.
        • Rajput T.
        • George A.T.
        • Park Y.
        Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review.
        Rheumatol Ther. 2020; : 1-23
        • Yong C.Y.
        • Hamilton J.
        • Benepal J.
        • Griffiths K.
        • Clark Z.E.
        • Rush A.
        • et al.
        Awareness of axial spondyloarthritis among chiropractors and osteopaths: findings from a UK Web-based survey.
        Rheumatol Adv Pract. 2019; 3 (rkz034)
        • Martindale J.
        • Goodacre L.
        The journey to diagnosis in AS/axial SpA: the impact of delay.
        Muscoskel Care. 2014; 12: 221-231
      2. Maguire S, Fitzgerald G, Sheehy C, O’shea FB. FRI0680 the association between ankylosing spondylitis and unemployment.

        • Rudwaleit M.
        • Listing J.
        • Brandt J.
        • Braun J.
        • Sieper J.
        Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis.
        Ann Rheumatic Dis. 2004; 63: 665-670
        • Cooksey R.
        • Husain M.J.
        • Brophy S.
        • Davies H.
        • Rahman M.A.
        • Atkinson M.D.
        • et al.
        The cost of ankylosing spondylitis in the UK using linked routine and patient-reported survey data.
        PloS One. 2015; 10
        • Nadin T.
        • Wallis D.
        • Holroyd C.R.
        • D'Angelo S.
        • Walker-Bone K.
        • Edwards C.J.
        Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?.
        BMC Muscoskel Disord. 2020; 21: 1-6
        • Hollick R.J.
        • Stelfox K.
        • Dean L.E.
        • Shim J.
        • Walker-Bone K.
        • Macfarlane G.J.
        Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register.
        Ann Rheum Dis. 2020 Aug 1; 79: 1055-1062
        • Barlow J.H.
        • Wright C.C.
        • Williams B.
        • Keat A.
        Work disability among people with ankylosing spondylitis.
        Arthritis Care Res. 2001; 45: 424-429
        • Shim J.
        • Jones G.T.
        • Pathan E.M.
        • Macfarlane G.J.
        Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis.
        Ann Rheumatic Dis. 2018; 77: 1578-1584
        • Maher C.
        • Underwood M.
        • Buchbinder R.
        Non-specific low back pain.
        Lancet. 2017; 389: 736-747
        • Wang R.
        • Crowson C.S.
        • Wright K.
        • Ward M.M.
        Clinical evolution in patients with new‐onset inflammatory back pain: a population‐based cohort study.
        Arthritis Rheumatol. 2018; 70: 1049-1055
      3. Sengupta R. Cook D. Gaffney K. The importance of targeting education strategies for complementary therapists dealing with potential axial spondyloarthritis patients Clinical and experimental rheumatology. ITALY, 2014 (CLINICAL & EXPER RHEUMATOLOGY VIA SANTA MARIA 31, 56126 PISA)
        • National Axial Spondyloarthritis Society
        NASS Allies | national axial spondyloarthritis society.
        ([online] Available at:)
        https://nass.co.uk/homepage/health-professionals/nass-allies
        Date: 2021
        Date accessed: February 14, 2021
        • NICE
        Recognition of symptoms by region in primary practice NHS.
        ([cited 02/03/2020]. Available from:)
        • Rudwaleit M.
        • Van Der Heijde D.
        • Landewé R.
        • Listing J.
        • Akkoc N.
        • Brandt J.
        • et al.
        The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
        Ann Rheumatic Dis. 2009; 68: 777-783
        • Sieper J.
        • Rudwaleit M.
        • Baraliakos X.
        • Brandt J.
        • Braun J.
        • Burgos-Vargas R.
        • et al.
        The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.
        Ann Rheumatic Dis. 2009; 68: ii1-ii44
        • Braun J.
        • Van Den Berg R.
        • Baraliakos X.
        • Boehm H.
        • Burgos-Vargas R.
        • Collantes-Estevez E.
        • et al.
        Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.
        Ann Rheumatic Dis. 2010; 70 (2011): 896-904
        • de Winter J.J.
        • Paramarta J.E.
        • de Jong H.M.
        • van de Sande M.G.
        • Baeten D.L.
        Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis.
        RMD open. 2019; 5
        • Fawkes C.
        • Leach C.
        • Mathias S.
        • Moore A.
        A profile of osteopathic care in private practices in the United Kingdom: a national pilot using standardised data collection.
        Man Ther. 2014; 19: 125-130
        • López-Medina C.
        • Dougados M.
        • Ruyssen-Witrand A.
        • Moltó A.
        Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort.
        Arthritis Res Ther. 2019; 21: 1-7
        • Bubová K.
        • Forejtová Š.
        • Zegzulková K.
        • Gregová M.
        • Hušáková M.
        • Filková M.
        • et al.
        Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort.
        BMJ open. 2019; 9 (e024713)
      4. Rothschild B.M. Pingitore C. Eaton M. Dactylitis: implications for clinical practice Seminars in arthritis and rheumatism. Elsevier, 1998
        • Kehl A.S.
        • Corr M.
        • Weisman M.H.
        Enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment.
        Arthritis Rheumatol. 2016 Feb; 68: 312-322
        • Sykes M.P.
        • Hamilton L.
        • Jones C.
        • Gaffney K.
        Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI.
        RMD open. 2018; 4 (e000553)
        • van der Horst-Bruinsma I.E.
        • Nurmohamed M.T.
        Management and evaluation of extra-articular manifestations in spondyloarthritis.
        Therapeut Adv Musculoskel Dis. 2012; 4: 413-422
        • Rudwaleit M.
        • Rosenbaum J.
        • Landewé R.
        • Marzo‐Ortega H.
        • Sieper J.
        • Van Der Heijde D.
        • et al.
        Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis.
        Arthritis Care Res. 2016; 68: 838-844
        • Sykes M.P.
        • Hamilton L.
        • Jones C.
        • Gaffney K.
        Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI.
        RMD open. 2018; 4
        • Haroon M.
        • O'Rourke M.
        • Ramasamy P.
        • Murphy C.C.
        • FitzGerald O.
        A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool).
        Ann Rheumatic Dis. 2015; 74: 1990-1995
        • Braun J.
        • Baraliakos X.
        • Listing J.
        • Sieper J.
        Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept.
        Arthritis Rheum: Off J Am Coll Rheumatol. 2005; 52: 2447-2451
        • adalinimumab N.I.C.E.
        NICE, 2020 ([cited 2020 20/02/20]. NICE BNF]. Available from:)
        • Kruh J.N.
        • Yang P.
        • Suelves A.M.
        • Foster C.S.
        Infliximab for the treatment of refractory noninfectious uveitis: a study of 88 patients with long-term follow-up.
        Ophthalmology. 2014 Jan 1; 121: 358-364
      5. Solmaz D. Bakirci S. Jibri Z. Sampaio M. Karsh J. Aydin S.Z. Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis Seminars in arthritis and rheumatism. Elsevier, 2020
        • de Winter J.J.
        • van Mens L.J.
        • van der Heijde D.
        • Landewé R.
        • Baeten D.L.
        Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.
        Arthritis Res Ther. 2016 Dec; 18: 1
        • Neurath M.F.
        Current and emerging therapeutic targets for IBD.
        Nat Rev Gastroenterol Hepatol. 2017; 14: 269-278
        • Karreman M.C.
        • Luime J.J.
        • Hazes J.M.
        • Weel A.E.
        The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis.
        J Crohn's Colitis. 2017; 11: 631-642
        • Hidalgo D.F.
        • Boonpheng B.
        • Phemister J.
        • Hidalgo J.
        • Young M.
        Inflammatory bowel disease and risk of osteoporotic fractures: a meta-analysis.
        Cureus. 2019; 11
        • Rudwaleit M.
        • Haibel H.
        • Baraliakos X.
        • Listing J.
        • Märker‐Hermann E.
        • Zeidler H.
        • et al.
        The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
        Arthritis Rheum: Off J Am Coll Rheumatol. 2009; 60: 717-727
        • Rudwaleit M.
        • Jurik A.G.
        • Hermann K.A.
        • Landewé R.
        • van der Heijde D.
        • Baraliakos X.
        • Marzo-Ortega H.
        • Østergaard M.
        • Braun J.
        • Sieper J.
        Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group.
        Ann Rheumatic Dis. 2009 Oct 1; 68: 1520-1527
        • Linden S.V.
        • Valkenburg H.A.
        • Cats A.
        Evaluation of diagnostic criteria for ankylosing spondylitis.
        Arthritis Rheum. 1984 Apr; 27: 361-368
        • de Hooge M.
        • van den Berg R.
        • Navarro-Compán V.
        • van Gaalen F.
        • van der Heijde D.
        • Huizinga T.
        • et al.
        Magnetic resonance imaging of the sacroiliac joints in the early detection of spondyloarthritis: no added value of gadolinium compared with short tau inversion recovery sequence.
        Rheumatology. 2013; 52: 1220-1224
        • Aouad K.
        • Ziade N.
        • Baraliakos X.
        Structural progression in axial spondyloarthritis.
        Joint Bone Spine. 2019;
        • Robinson P.C.
        • Sengupta R.
        • Siebert S.
        Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy.
        Rheumatol Ther. 2019; 6: 165-177
        • Protopopov M.
        • Poddubnyy D.
        Radiographic progression in non-radiographic axial spondyloarthritis.
        Expet Rev Clin Immunol. 2018; 14: 525-533
        • Seo M.R.
        • Baek H.L.
        • Yoon H.H.
        • Ryu H.J.
        • Choi H.-J.
        • Baek H.J.
        • et al.
        Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis.
        Clin Rheumatol. 2015; 34: 1397-1405
        • Poddubnyy D.
        • Rudwaleit M.
        • Haibel H.
        • Listing J.
        • Märker-Hermann E.
        • Zeidler H.
        • et al.
        Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.
        Ann Rheumatic Dis. 2011; 70: 1369-1374
        • Isdale A.
        • Keat A.
        • Barkham N.
        • Bennett A.N.
        • Gaffney K.
        • Marzo-Ortega H.
        • et al.
        Expanding the spectrum of inflammatory spinal disease: AS it was, as it is now.
        Oxford University Press, 2013
        • Sieper J.
        • Rudwaleit M.
        How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?.
        Ann Rheumatic Dis. 2005; 64: iv61-i64
        • Patel P.
        • Hussain H.
        • Fahey J.
        Delayed diagnosis of ankylosing spondylitis: a missed opportunity?.
        Cureus. 2019; 11
        • Redeker I.
        • Callhoff J.
        • Hoffmann F.
        • Haibel H.
        • Sieper J.
        • Zink A.
        • et al.
        Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data.
        Rheumatology. 2019; 58: 1634-1638
        • Swinnen T.W.
        • Westhovens R.
        • Dankaerts W.
        • De Vlam K.
        Widespread pain in axial spondyloarthritis: clinical importance and gender differences.
        Arthritis Res Ther. 2018; 20: 156
        • Baraliakos X.
        • Regel A.
        • Kiltz U.
        • Kiefer D.
        • Menne H.-J.
        • Dybowski F.
        • et al.
        OP0038 patients with fibromyalgia (FM) do not fulfill classification criteria for axial spondyloarthritis (AXSPA) but patients with axspa may fulfill classification criteria for FM.
        BMJ Publishing Group Ltd, 2015
      6. Gareth TJ, Bhadra M, Joanna S, Jonathan L, Gary JM. The prevalence of fibromyalgia in axial spondyloarthritis. Rheumatol Int.

      7. Spadetool.co.UK. 2021 (SPADE Tool. [online] Available at:)
        http://www.spadetool.co.uk/
        Date accessed: February 14, 2021
        • Braun J.
        • Bollow M.
        • Remlinger G.
        • Eggens U.
        • Rudwaleit M.
        • Distler A.
        • Sieper J.
        Prevalence of spondylarthropathies in HLA‐B27 positive and negative blood donors.
        Arthritis Rheum: Off J Am Coll Rheumatol. 1998 Jan; 41: 58-67
        • van Lunteren M.
        • van der Heijde D.
        • Sepriano A.
        • Berg I.J.
        • Dougados M.
        • Gossec L.
        • et al.
        Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?.
        Rheumatology. 2019; 58: 1649-1654
        • Brown M.A.
        • Kennedy L.G.
        • Macgregor A.J.
        • Darke C.
        • Duncan E.
        • Shatford J.L.
        • et al.
        Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment.
        Arthritis Rheum. 1997; 40: 1823-1828
        • Turina M.C.
        • Yeremenko N.
        • van Gaalen F.
        • van Oosterhout M.
        • Berg I.J.
        • Ramonda R.
        • et al.
        Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort.
        RMD open. 2017; 3 (e000319)
      8. Exercise for ankylosing spondylitis: an evidence-based consensus statement.
        in: Millner J.R. Barron J.S. Beinke K.M. Butterworth R.H. Chasle B.E. Dutton L.J. Seminars in arthritis and rheumatism. Elsevier, 2016
        • Dundar U.
        • Solak O.
        • Toktas H.
        • Demirdal U.S.
        • Subasi V.
        • Kavuncu V.U.
        • Evcik D.
        Effect of aquatic exercise on ankylosing spondylitis: a randomized controlled trial.
        Rheumatol Int. 2014 Nov 1; 34: 1505-1511
        • Analay Y.
        • Ozcan E.
        • Karan A.
        • Diracoglu D.
        • Aydin R.
        The effectiveness of intensive group exercise on patients with ankylosing spondylitis.
        Clin Rehabil. 2003; 17: 631-636
        • Zão A.
        • Cantista P.
        The role of land and aquatic exercise in ankylosing spondylitis: a systematic review.
        Rheumatol Int. 2017; 37: 1979-1990
        • Pécourneau V.
        • Degboé Y.
        • Barnetche T.
        • Cantagrel A.
        • Constantin A.
        • Ruyssen-Witrand A.
        Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials.
        Arch Phys Med Rehabil. 2018; 99 (e1): 383-389
        • Saracoglu I.
        • Kurt G.
        • Okur E.O.
        • Afsar E.
        • Seyyar G.K.
        • Calik B.B.
        • et al.
        The effectiveness of specific exercise types on cardiopulmonary functions in patients with ankylosing spondylitis: a systematic review.
        Rheumatol Int. 2017; 37: 409-421
        • O'Dwyer T.
        • McGowan E.
        • O'Shea F.
        • Wilson F.
        Physical activity and exercise: perspectives of adults with ankylosing spondylitis.
        J Phys Activ Health. 2016; 13: 504-513
        • Dagfinrud H.
        • Hagen K.B.
        • Kvien T.K.
        Physiotherapy interventions for ankylosing spondylitis.
        Cochrane Database Syst Rev. 2008;
        • Regel A.
        • Sepriano A.
        • Baraliakos X.
        • van der Heijde D.
        • Braun J.
        • Landewé R.
        • et al.
        Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
        RMD open. 2017; 3 (e000397)
        • Zochling J.
        • van der Heijde D.
        • Burgos-Vargas R.
        • Collantes E.
        • Davis J.C.
        • Dijkmans B.
        • et al.
        ASAS/EULAR recommendations for the management of ankylosing spondylitis.
        Ann Rheumatic Dis. 2006; 65: 442-452
        • Sieper J.
        • Poddubnyy D.
        New evidence on the management of spondyloarthritis.
        Nat Rev Rheumatol. 2016; 12: 282
        • Fine M.
        Quantifying the impact of NSAID-associated adverse events.
        Am J Manag Care. 2013; 19: s267-s272
        • Baraliakos X.
        • Listing J.
        • Rudwaleit M.
        • Brandt J.
        • Sieper J.
        • Braun J.
        Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab.
        Ann Rheumatic Dis. 2005; 64: 1462-1466
        • Macfarlane T.V.
        • Abbood H.M.
        • Pathan E.
        • Gordon K.
        • Hinz J.
        • Macfarlane G.J.
        Relationship between diet and ankylosing spondylitis: a systematic review.
        Eur J Rheumatol. 2018; 5: 45
        • NHS Direct
        The eatwell plate.
        • Pray C.
        • Feroz N.I.
        • Haroon N.N.
        Bone mineral density and fracture risk in ankylosing spondylitis: a meta-analysis.
        Calcif Tissue Int. 2017; 101: 182-192
        • Briot K.
        • Roux C.
        Inflammation, bone loss and fracture risk in spondyloarthritis.
        RMD open. 2015; 1 (e000052)
        • Garrett S.
        • Jenkinson T.
        • Kennedy L.G.
        • Whitelock H.
        • Gaisford P.
        • Calin A.
        A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
        J Rheumatol. 1994; 21: 2286-2291
        • Martindale J.H.
        • Sutton C.J.
        • Goodacre L.
        An exploration of the inter-and intra-rater reliability of the Bath ankylosing spondylitis Metrology index.
        Clin Rheumatol. 2012; 31: 1627-1631
        • van Weely S.F.
        • van Denderen C.J.
        • van der Horst-Bruinsma I.E.
        • Nurmohamed M.T.
        • Dijkmans B.A.
        • Dekker J.
        • et al.
        Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis.
        Rheumatology. 2009; 48: 1254-1260
        • Jordan A.
        • Family H.
        • Blaxall K.
        • Begen F.M.
        • Sengupta R.
        Use of complementary and alternative medicine in axial spondyloarthritis: a qualitative exploration of self-management.
        J Clin Med. 2019; 8: 699
        • Family H.
        • Jordan A.
        • Blaxall K.
        • Sengupta R.
        A truly complementary approach: a qualitative exploration of complementary and alternative medicine practitioners' views of treating ankylosing spondylitis.
        Muscoskel Care. 2018; 16: 96-102
        • NASS
        NASS Allies.
        • Hilal Telli M.
        • Serkan Telli M.
        • Murat Topal M.
        The validity and reliability of provocation tests in the diagnosis of sacroiliac joint dysfunction.
        Pain Physician. 2018; 21: E367-E376
        • Szadek K.M.
        • van der Wurff P.
        • van Tulder M.W.
        • Zuurmond W.W.
        • Perez R.S.
        Diagnostic validity of criteria for sacroiliac joint pain: a systematic review.
        J Pain. 2009; 10: 354-368
        • Castro M.P.
        • Stebbings S.M.
        • Milosavljevic S.
        • Pedersen S.J.
        • Bussey M.D.
        Assessing the construct validity of clinical tests to identify sacroiliac joint inflammation in patients with non‐radiographic axial spondyloarthritis.
        Int J Rheumatic Dis. 2019; 22: 1521-1528
        • Haneline M.T.
        • Young M.
        A review of intraexaminer and interexaminer reliability of static spinal palpation: a literature synthesis.
        J Manipulative Physiol Therapeut. 2009; 32: 379-386
        • Seffinger M.A.
        • Najm W.I.
        • Mishra S.I.
        • Adams A.
        • Dickerson V.M.
        • Murphy L.S.
        • et al.
        Reliability of spinal palpation for diagnosis of back and neck pain: a systematic review of the literature.
        Spine. 2004; 29: E413-E425
        • Passalent L.A.
        Physiotherapy for ankylosing spondylitis: evidence and application.
        Curr Opin Rheumatol. 2011; 23: 142-147
        • Neumann A.
        • Haschka J.
        • Kleyer A.
        • Schuster L.
        • Englbrecht M.
        • Berlin A.
        • et al.
        Cortical bone loss is an early feature of nonradiographic axial spondyloarthritis.
        Arthritis Res Ther. 2018; 20: 202
        • Østergaard M.
        Imaging of ankylosing spondylitis.
        Arthritis Res Ther. 2012 Dec; 14 ([BioMed Central]): 1-8